Runben Biotechnology released its first-quarter performance, with a net profit attributable to the parent company of 44.2 million yuan, a year-on-year increase of 24.60%
I'm LongbridgeAI, I can summarize articles.According to the Zhitong Finance APP, Runben Biotechnology disclosed its first-quarter report for 2025, showing that the company achieved revenue of 240 million yuan during the reporting period, a year-on-year increase of 44%; net profit attributable to the parent company was 44.2 million yuan, a year-on-year increase of 24.60%; and net profit excluding non-recurring gains and losses was 38.62 million yuan, a year-on-year increase of 22.85%. Basic earnings per share were 0.11 yuan
According to the Zhitong Finance APP, Runben Biotechnology (603193.SH) disclosed its first-quarter report for 2025. During the reporting period, the company achieved revenue of 240 million yuan, a year-on-year increase of 44%; net profit attributable to the parent company was 44.2 million yuan, a year-on-year increase of 24.60%; and net profit excluding non-recurring gains and losses was 38.62 million yuan, a year-on-year increase of 22.85%. Basic earnings per share were 0.11 yuan